Clinical Study
Predictors of Venous Thromboembolic Events Associated with Central Venous Port Insertion in Cancer Patients
Table 2
Incidence of thrombotic events at 3 months and 12 months (proportion and CI95).
| |
3 months
|
12 months
| | All events | Symptomatic events | All events | Symptomatic events |
| Subclavian DVT | 3.0% (1.9–4.0) | 2.1% (1.2–3.1) | 5.9% (4.5–7.8) | 4.1% (2.7–5.4) | PE | 3.0% (1.9–4.0) | 1.4% (0.7–2.1) | 5.5% (4.1–6.9) | 2.7% (1.6–3.7) | Catheter-related event (subclavian DVT or PE) | 5.9% (4.4–7.3) | 3.6% (2.4–4.7) | 11.3% (9.4–13.2) | 6.7% (5.1–8.4) | Lower extremity or visceral DVT | 2.2% (1.3–3.1) | 1.3% (0.6–2.1) | 4.6% (3.3–5.9) | 2.8% (1.7–3.9) | All thrombotic events | 7.6% (6.0–9.3) | 4.7% (3.4–6.0) | 15.3% (13.1–17.6) | 9.3% (7.3–11.2) |
|
|